InMed Pharmaceuticals Ownership | Who Owns InMed Pharmaceuticals?


OverviewRevenueFinancialsChart

InMed Pharmaceuticals Ownership Summary


InMed Pharmaceuticals is owned by 0.18% institutional investors, 0.62% insiders, and 99.20% retail investors. Virtu financial is the largest institutional shareholder, holding 0.90% of INM shares. AdvisorShares Pure Cannabis ETF is the top mutual fund, with 6.24% of its assets in InMed Pharmaceuticals shares.

INM Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockInMed Pharmaceuticals0.18%0.62%99.20%
SectorHealthcare Stocks 47.06%8.01%44.93%
IndustryBiotech Stocks 44.97%7.82%47.21%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Virtu financial86.68K0.90%$23.00K
Hrt financial lp16.00K0.17%$4.00K
Citadel advisors12.10K0.13%$3.21K
Bank of america corp /de/100.000.00%$26.00
Advisor group32.000.00%$7.00
Allsquare wealth management21.000.00%$6.00
Global retirement partners6.000.00%$2.00
Toronto dominion bank---
Ubs group---
Xtx topco---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Virtu financial86.68K0.00%$23.00K
Renaissance---
Bfsg---
Two sigma securities---
Td waterhouse canada---
Federation des caisses desjardins du quebec---
Advisor group32.00-$7.00
Bank of america corp /de/100.00-$26.00
Advisornet financial---
Toronto dominion bank---

Top Buyers

HolderShares% AssetsChange
Virtu financial86.68K0.00%86.68K
Hrt financial lp16.00K-16.00K
Allsquare wealth management21.00--
Bank of america corp /de/100.00--
Global retirement partners6.00--

Top Sellers

HolderShares% AssetsChange
Sabby management---307.24K
Armistice capital---266.97K
Renaissance---28.30K
Xtx topco---17.82K
Two sigma securities---15.42K

New Positions

HolderShares% AssetsChangeValue
Virtu financial86.68K0.00%86.68K$23.00K
Hrt financial lp16.00K-16.00K$4.00K

Sold Out

HolderChange
Toronto dominion bank-2.00
National bank of canada /fi/-12.00
Federation des caisses desjardins du quebec-19.00
Ubs group-41.00
Advisornet financial-80.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202411-8.33%1,113,450152.90%-0.86%775.00%1-66.67%
Jun 30, 202412-25.00%440,278-35.81%46.19%4-20.00%3-
Mar 31, 2024166.67%685,866-14.72%88.45%5-44.44%350.00%
Dec 31, 20231566.67%804,2502893.45%10837.71%950.00%2-
Sep 30, 2023912.50%26,86770.75%1490.91%6200.00%--100.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
AdvisorShares Pure Cannabis ETF833.30K6.24%-

Recent Insider Transactions


DateNameRoleActivityValue
Jul 31, 2024MANCINI ALEXANDRA DIANE JANET ConsultantSell$42.31
Feb 21, 2024HULL ANDREW-Buy$14.63K
Feb 20, 2024ADAMS ERIC A President & CEOBuy$14.92K
Apr 14, 2022ADAMS ERIC A President & CEOBuy$12.66K
Apr 13, 2022ADAMS ERIC A President & CEOBuy$7.28K

Insider Transactions Trends


DateBuySell
2024 Q3-1
2024 Q2--
2024 Q12-
2023 Q4--
2023 Q3--

INM Ownership FAQ


Who Owns InMed Pharmaceuticals?

InMed Pharmaceuticals shareholders are primarily institutional investors at 0.18%, followed by 0.62% insiders and 99.20% retail investors. The average institutional ownership in InMed Pharmaceuticals's industry, Biotech Stocks , is 44.97%, which InMed Pharmaceuticals falls below.

Who owns the most shares of InMed Pharmaceuticals?

InMed Pharmaceuticals’s largest shareholders are Virtu financial (86.68K shares, 0.90%), Hrt financial lp (16K shares, 0.17%), and Citadel advisors (12.1K shares, 0.13%). Together, they hold 1.19% of InMed Pharmaceuticals’s total shares outstanding.

Does Blackrock own InMed Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of InMed Pharmaceuticals.

Who is InMed Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Virtu financial is InMed Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 0.00% of its assets in 86.68K InMed Pharmaceuticals shares, valued at 23K$.

Who is the top mutual fund holder of InMed Pharmaceuticals shares?

AdvisorShares Pure Cannabis ETF is the top mutual fund holder of InMed Pharmaceuticals shares, with 6.24% of its total shares outstanding invested in 833.3K InMed Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools